These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28089362)

  • 41. Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.
    Yamasaki R; Kanda J; Akahoshi Y; Nakano H; Ugai T; Wada H; Kawamura K; Ishihara Y; Sakamoto K; Sato M; Ashizawa M; Machishima T; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kako S; Nishida J; Kanda Y
    Int J Hematol; 2017 Jun; 105(6):835-840. PubMed ID: 28168415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of pharmacokinetics/pharmacodynamics of levofloxacin].
    Zhang J; Yu JC; Shi YG; Zhou L; Ye XY; Zhu DM; Zhang YY
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1926-32. PubMed ID: 16255991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
    Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration.
    George JM; Fiscella R; Blair M; Rodvold K; Ulanski L; Stokes J; Blair N; Pontiggia L
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):579-86. PubMed ID: 20977368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Prospective Study of the Efficacy, Safety and Pharmacokinetics of Enteral Moxifloxacin in the Treatment of Hemodialysis Patients with Pneumonia.
    Tokimatsu I; Shigemura K; Kotaki T; Yoshikawa H; Yamamichi F; Tomo T; Arakawa S; Fujisawa M; Kadota JI
    Intern Med; 2017; 56(11):1315-1319. PubMed ID: 28566592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
    Tanimura H; Ohnishi H; Okamura T; Uenishi M; Ichimiya G; Kobayashi Y; Aoki Y; Oka S; Yamamoto S; Shimada K
    Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population pharmacokinetics of levofloxacin as prophylaxis for febrile neutropenia.
    Nomura K; Fujimoto Y; Morimoto Y; Kanbayashi Y; Matsumoto Y; Taniwaki M
    Intern Med; 2008; 47(5):375-8. PubMed ID: 18310966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of fluoroquinolone penetration into human conjunctival tissue.
    Aihara M; Miyanaga M; Minami K; Miyata K; Eguchi S; Shiroma H; Sawaguchi S
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):587-91. PubMed ID: 19049265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers.
    Park SI; Oh J; Jang K; Yoon J; Moon SJ; Park JS; Lee JH; Song J; Jang IJ; Yu KS; Chung JY
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4429-35. PubMed ID: 25987620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetic and clinical evaluation of levofloxacin in obstetrics and gynecology].
    Cho N; Araki H; Kimura T; Shimizu A; Ichikawa K; Fukunaga K; Kunii K
    Jpn J Antibiot; 1992 Mar; 45(3):270-84. PubMed ID: 1512924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery.
    Holland EJ; McCarthy M; Holland S
    Curr Med Res Opin; 2007 Dec; 23(12):2955-60. PubMed ID: 17939882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aqueous penetration of gatifloxacin and levofloxacin into the rabbit aqueous humor following topical dosing.
    Levine JM; Noecker RJ; Lane LC; Snyder RW; Rapedius M; Blanchard J
    J Ocul Pharmacol Ther; 2004 Jun; 20(3):210-6. PubMed ID: 15279726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.
    Sidhu PK; Landoni MF; Aliabadi MH; Toutain PL; Lees P
    J Vet Pharmacol Ther; 2011 Aug; 34(4):376-87. PubMed ID: 21091727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient penetration into aqueous humor by administration of oral and topical levofloxacin.
    Ishida M; Kataoka T; Niwa K; Iwaki M; Zako M
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):247-50. PubMed ID: 21548793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.
    Proksch JW; Granvil CP; Siou-Mermet R; Comstock TL; Paterno MR; Ward KW
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):335-44. PubMed ID: 19492955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.
    Hurtado FK; Weber B; Derendorf H; Hochhaus G; Dalla Costa T
    Antimicrob Agents Chemother; 2014; 58(2):678-86. PubMed ID: 24217697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic study of enrofloxacin in Nile tilapia (Oreochromis niloticus) after a single oral administration in medicated feed.
    Teles JA; Castello Branco LC; Del Bianchi M; Pilarski F; Reyes FG
    J Vet Pharmacol Ther; 2016 Apr; 39(2):205-8. PubMed ID: 26270353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes.
    Yamada M; Ishikawa K; Mochizuki H; Kawai M
    Acta Ophthalmol Scand; 2006 Apr; 84(2):192-6. PubMed ID: 16637835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue penetration of sparfloxacin in a rat model of experimental Escherichia coli epididymitis.
    Ludwig M; Jantos CA; Wolf S; Bergmann M; Failing K; Schiefer HG; Weidner W
    Infection; 1997; 25(3):178-84. PubMed ID: 9181388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice].
    Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Fujikawa K; Namba K; Otani T; Yamaguchi K
    Jpn J Antibiot; 2009 Oct; 62(5):452-9. PubMed ID: 20055122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.